Analysts/Institutional Investor Meet/Con. Call Updates Laurus Labs Limited has informed the Exchange about Transcript
27 Jul 2023
-
I had two questions around our CDMO business, the last two years has been a bit of a topsy - turvy period wherein it is also given as an opportunity to do projects that really push us to the next level. So, can you just share some of the strengths around our CDMO business, what makes us a unique player compared to the other CDMO players? Where do our strengths lie?
Read in transcript -
And my first question around what makes our CDMO business a differentiated business
Read in transcript -
And if you are comfortable sharing in our CDMO business today how much would be business from commercial molecules and how much would be more early stage?
Read in transcript